46,900 Shares in Genpact Limited (NYSE:G) Acquired by Louisiana State Employees Retirement System

→ Dems have chosen Biden replacement? (From Paradigm Press) (Ad)

Louisiana State Employees Retirement System acquired a new position in shares of Genpact Limited (NYSE:G - Free Report) in the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor acquired 46,900 shares of the business services provider's stock, valued at approximately $1,628,000.

Other institutional investors have also recently added to or reduced their stakes in the company. Moneta Group Investment Advisors LLC grew its stake in shares of Genpact by 103,311.3% in the fourth quarter. Moneta Group Investment Advisors LLC now owns 4,937,889 shares of the business services provider's stock worth $228,723,000 after purchasing an additional 4,933,114 shares in the last quarter. Capital International Investors grew its stake in shares of Genpact by 101.8% in the first quarter. Capital International Investors now owns 3,963,229 shares of the business services provider's stock worth $172,440,000 after purchasing an additional 1,999,617 shares in the last quarter. Norges Bank bought a new position in shares of Genpact in the fourth quarter worth $81,569,000. FMR LLC grew its stake in shares of Genpact by 8.1% in the third quarter. FMR LLC now owns 17,644,694 shares of the business services provider's stock worth $638,738,000 after purchasing an additional 1,327,435 shares in the last quarter. Finally, Millennium Management LLC grew its stake in shares of Genpact by 416.0% in the fourth quarter. Millennium Management LLC now owns 918,348 shares of the business services provider's stock worth $42,538,000 after purchasing an additional 740,389 shares in the last quarter. 96.03% of the stock is currently owned by institutional investors.


Genpact Stock Up 2.3 %

G stock traded up $0.70 during mid-day trading on Friday, hitting $31.59. The stock had a trading volume of 1,297,309 shares, compared to its average volume of 1,543,101. The company has a current ratio of 1.44, a quick ratio of 1.44 and a debt-to-equity ratio of 0.37. Genpact Limited has a 1-year low of $29.41 and a 1-year high of $44.96. The company has a fifty day moving average of $33.51 and a 200 day moving average of $34.28. The stock has a market capitalization of $5.70 billion, a price-to-earnings ratio of 9.21, a PEG ratio of 1.45 and a beta of 1.07.

Genpact (NYSE:G - Get Free Report) last issued its quarterly earnings data on Thursday, February 8th. The business services provider reported $0.68 EPS for the quarter, beating analysts' consensus estimates of $0.65 by $0.03. Genpact had a return on equity of 23.19% and a net margin of 14.10%. The business had revenue of $1.15 billion for the quarter, compared to analyst estimates of $1.12 billion. On average, equities analysts expect that Genpact Limited will post 2.7 EPS for the current fiscal year.

Genpact Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 26th. Shareholders of record on Monday, March 11th were given a $0.153 dividend. The ex-dividend date was Friday, March 8th. This represents a $0.61 dividend on an annualized basis and a dividend yield of 1.94%. This is an increase from Genpact's previous quarterly dividend of $0.14. Genpact's dividend payout ratio (DPR) is currently 17.78%.

Analyst Upgrades and Downgrades

G has been the subject of several research analyst reports. Needham & Company LLC restated a "buy" rating and issued a $40.00 price objective on shares of Genpact in a report on Friday, February 9th. JPMorgan Chase & Co. upped their price objective on Genpact from $42.00 to $43.00 and gave the company an "underweight" rating in a report on Friday, February 9th. Mizuho started coverage on Genpact in a report on Tuesday, January 30th. They issued a "neutral" rating and a $40.00 price objective for the company. StockNews.com downgraded Genpact from a "strong-buy" rating to a "buy" rating in a report on Friday, April 5th. Finally, Citigroup upped their target price on Genpact from $35.00 to $36.00 and gave the company a "neutral" rating in a report on Wednesday, January 17th. One analyst has rated the stock with a sell rating, five have issued a hold rating and two have given a buy rating to the company's stock. According to MarketBeat, the company has a consensus rating of "Hold" and a consensus target price of $40.11.

Get Our Latest Stock Analysis on Genpact

Insiders Place Their Bets

In other Genpact news, SVP Heather White sold 11,450 shares of the firm's stock in a transaction that occurred on Monday, January 22nd. The stock was sold at an average price of $36.00, for a total value of $412,200.00. Following the completion of the sale, the senior vice president now owns 21,175 shares in the company, valued at approximately $762,300. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Corporate insiders own 2.80% of the company's stock.

Genpact Company Profile

(Free Report)

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.

Featured Articles

Institutional Ownership by Quarter for Genpact (NYSE:G)

→ Dems have chosen Biden replacement? (From Paradigm Press) (Ad)

Should you invest $1,000 in Genpact right now?

Before you consider Genpact, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.

While Genpact currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Featured Articles and Offers

7 Must-Buy Stocks Under $20

7 Must-Buy Stocks Under $20

In this video, we highlight seven stocks under $20 that are worth a closer look.

Search Headlines: